Skip to content

ACAD · Acadia Pharmaceuticals Inc

Healthcare

☆ Add to watchlist

Updated Oct 29 · 14 feeds behind: Congress trades, 20 days, and 13 more · Every feed →

On this page

The market view

Price chart

The interactive ACAD chart (by TradingView) loads here.

Our take

2 rules fired on ACAD

In short: none of these rules has solid or some evidence yet, so they show no clear lean on ACAD.

How each did in past tests, against similar stocks over 3 months. Past results don't predict future ones.

The 0–100 score for ACAD, and which of these rules are open on it right now
Members see one number for how strongly these rules agree on ACAD, and the day each rule fired. Better-tested rules count more, and so do different kinds of filings that point the same way.
See pricing →
Already a member? Sign in

Compare with this company’s history

Is disclosure activity unusual?

See how many different insiders or members of Congress reported purchases or sales of ACAD. Each bar covers 28 days, by disclosure date. Several trades by one person count once in each group and period.

Latest period: Oct 10, 2026–Nov 6, 2026 · UTC dates · today is excluded

Insider purchases

Source needs an update

The feed’s newest disclosure is too old for a current comparison. Counts show only the records already stored.

Latest 28 days
0
Earlier median
0
Earlier range
0–0
Distinct filers per 28 daysScale: 0–1
Nov 8, 2025Nov 6, 2026
Earlier periodsLatest 28 daysEarlier median 0Limited or missing history

Who appears in the latest period?

No named filers on file for this period.

Up to three filers; one example disclosure each.

Inspect this period’s filings

The history behind this view

First stored company disclosure: Jun 29, 2026. Newest disclosure across this feed: Oct 27, 2026.

Earlier periods in the comparison: 3. Outlined periods are missing data, so they are left out of the comparison. The chart scale changes with the category.

Exact counts, dates and filings for all four categories
Insider purchases · Source needs an update

The feed’s newest disclosure is too old for a current comparison. Counts show only the records already stored. Earlier median: 0; range: 0–0.

Insider purchases: distinct filers in stored disclosures
Period and filingsFilersHistory
Nov 8, 2025–Dec 5, 2025—Unavailable
Dec 6, 2025–Jan 2, 2026—Unavailable
Jan 3, 2026–Jan 30, 2026—Unavailable
Jan 31, 2026–Feb 27, 2026—Unavailable
Feb 28, 2026–Mar 27, 2026—Unavailable
Mar 28, 2026–Apr 24, 2026—Unavailable
Apr 25, 2026–May 22, 2026—Unavailable
May 23, 2026–Jun 19, 2026—Unavailable
Jun 20, 2026–Jul 17, 20260Partial; excluded
Jul 18, 2026–Aug 14, 20260Within stored history
Aug 15, 2026–Sep 11, 20260Within stored history
Sep 12, 2026–Oct 9, 20260Within stored history
Oct 10, 2026–Nov 6, 2026Latest period0Partial; excluded
Insider sales · Source needs an update

The feed’s newest disclosure is too old for a current comparison. Counts show only the records already stored. Earlier median: 0; range: 0–2.

Insider sales: distinct filers in stored disclosures
Period and filingsFilersHistory
Nov 8, 2025–Dec 5, 2025—Unavailable
Dec 6, 2025–Jan 2, 2026—Unavailable
Jan 3, 2026–Jan 30, 2026—Unavailable
Jan 31, 2026–Feb 27, 2026—Unavailable
Feb 28, 2026–Mar 27, 2026—Unavailable
Mar 28, 2026–Apr 24, 2026—Unavailable
Apr 25, 2026–May 22, 2026—Unavailable
May 23, 2026–Jun 19, 2026—Unavailable
Jun 20, 2026–Jul 17, 20261Partial; excluded
Jul 18, 2026–Aug 14, 20262Within stored history
Aug 15, 2026–Sep 11, 20260Within stored history
Sep 12, 2026–Oct 9, 20260Within stored history
Oct 10, 2026–Nov 6, 2026Latest period0Partial; excluded
Congress purchases · Source needs an update

The feed’s newest disclosure is too old for a current comparison. Counts show only the records already stored. Earlier median: —; range: unavailable.

Congress purchases: distinct filers in stored disclosures
Period and filingsFilersHistory
Nov 8, 2025–Dec 5, 2025—Unavailable
Dec 6, 2025–Jan 2, 2026—Unavailable
Jan 3, 2026–Jan 30, 2026—Unavailable
Jan 31, 2026–Feb 27, 2026—Unavailable
Feb 28, 2026–Mar 27, 2026—Unavailable
Mar 28, 2026–Apr 24, 2026—Unavailable
Apr 25, 2026–May 22, 2026—Unavailable
May 23, 2026–Jun 19, 2026—Unavailable
Jun 20, 2026–Jul 17, 2026—Unavailable
Jul 18, 2026–Aug 14, 2026—Unavailable
Aug 15, 2026–Sep 11, 2026—Unavailable
Sep 12, 2026–Oct 9, 2026—Unavailable
Oct 10, 2026–Nov 6, 2026Latest period—Unavailable
Congress sales · Source needs an update

The feed’s newest disclosure is too old for a current comparison. Counts show only the records already stored. Earlier median: —; range: unavailable.

Congress sales: distinct filers in stored disclosures
Period and filingsFilersHistory
Nov 8, 2025–Dec 5, 2025—Unavailable
Dec 6, 2025–Jan 2, 2026—Unavailable
Jan 3, 2026–Jan 30, 2026—Unavailable
Jan 31, 2026–Feb 27, 2026—Unavailable
Feb 28, 2026–Mar 27, 2026—Unavailable
Mar 28, 2026–Apr 24, 2026—Unavailable
Apr 25, 2026–May 22, 2026—Unavailable
May 23, 2026–Jun 19, 2026—Unavailable
Jun 20, 2026–Jul 17, 2026—Unavailable
Jul 18, 2026–Aug 14, 2026—Unavailable
Aug 15, 2026–Sep 11, 2026—Unavailable
Sep 12, 2026–Oct 9, 2026—Unavailable
Oct 10, 2026–Nov 6, 2026Latest period—Unavailable
How to read this comparison

The median is the middle count in up to 12 earlier, non-overlapping 28-day periods; the range runs from the smallest to the largest count. The latest period is excluded from both. A comparison needs at least 6 earlier periods, including 3 with activity. The feed’s latest disclosure must be within 7 days of the current period’s end. This freshness check does not verify complete collection.

Insiders include individuals and reporting entities; only purchase and sale codes enter this view. Congress counts reporting members, including their disclosed family transactions. The same filer can appear in purchases and sales, so these categories should not be added into a net count.

These are stored disclosures, not a complete measure of trading. Reporting delays and collection gaps can change the comparison. More activity does not identify a motive or predict a stock’s return.

Company timeline

What has been happening?

May 1, 2026–Oct 27, 2026. Select a month in a category to inspect its records.

Company filings

Insiders

FDA & trials

Owners & lobbying

All 22 records in this snapshot
  1. Filed
  2. Record date
  3. Record date
    Lobbying for Acadia Pharmaceuticals Inc. ↗

    $20K · by Holland & Knight LLP

  4. Filed
  5. Filed
  6. Filed
  7. Record date
  8. Filed
  9. Record date
  10. Disclosed
    Mark C. Schneyer · Sale

    Transaction dated Aug 6, 2026

  11. Disclosed
    Mark C. Schneyer · Sale

    Transaction dated Aug 5, 2026

  12. Disclosed
    Mark C. Schneyer · Sale

    Transaction dated Aug 6, 2026

  13. Filed
  14. Filed
  15. Disclosed
    Elizabeth H.Z. Thompson · Sale

    Transaction dated Jul 30, 2026

  16. Disclosed
    Elizabeth H.Z. Thompson · Sale

    Transaction dated Jul 30, 2026

  17. Record date
    Lobbying for Acadia Pharmaceuticals ↗

    $700K · by Acadia Pharmaceuticals

  18. Record date
  19. Record date
    Lobbying for Acadia Pharmaceuticals Inc. ↗

    $20K · by Holland & Knight LLP

  20. Disclosed
    James Kihara · Sale

    Transaction dated Jun 26, 2026

  21. Filed
  22. Filed

Month counts include every record on file. The lists show the newest records on this page. A dash means none on file that month. Trades use disclosure dates; contract dates follow the source record. Nearby events do not establish the cause of a price move.

Who's buying and selling · last 90 days

Congress

No Congress trades on ACAD disclosed in the last 90 days.

See every Congress trade on ACAD →

Company insiders

0 buys · 2 sells (5 filed lots) · $1M sold

  1. ▼ SELLMark C. Schneyer EVP, Chief Financial OfficerACAD Acadia Pharmaceuticals Inc$273Kdisclosed Aug 7 · filed 1 day after the trade
  2. ▼ SELLMark C. Schneyer EVP, Chief Financial OfficerACAD Acadia Pharmaceuticals Inc$170Kdisclosed Aug 7 · filed 2 days after the trade
  3. ▼ SELLMark C. Schneyer EVP, Chief Financial OfficerACAD Acadia Pharmaceuticals Inc$145Kdisclosed Aug 7 · filed 1 day after the trade
  4. ▼ SELLElizabeth H.Z. Thompson EVP, Head of Research & DevACAD Acadia Pharmaceuticals Inc$431Kdisclosed Jul 31 · filed 1 day after the trade
  5. ▼ SELLElizabeth H.Z. Thompson EVP, Head of Research & DevACAD Acadia Pharmaceuticals Inc$1.3Kdisclosed Jul 31 · filed 1 day after the trade
See every insider trade on ACAD →

Big holders (Schedule 13D / 13G): 1 filing in the last 90 days · newest: State Street Corp (13G), Aug 7, 2026 ↗

Filings & events

Company filings (8-K) 44

Events the company must report to the SEC within days — results, deals, departures, restatements.

What it files 8-Ks about

  • Quarterly or yearly results · item 2.0211
  • Directors or officers joined, left or got new pay · item 5.027
  • Other events · item 8.014
  • Shared information with investors · item 7.013
  • Shareholder vote results · item 5.073
  • Signed a major agreement · item 1.011

Filing red flags 18

Warning signs in the company's own SEC filings — going-concern doubts, control weaknesses, staff comment letters, late filings, restatements, Wells notices, clinical holds, dividend cuts.

FDA and clinical trials 24

Drug approvals, recalls, clinical-trial updates and FDA advisory meetings.

Lobbying 66

Lobbying reports filed with the Senate for the company.

$9.7M across 66 reports

Issues named in the most reports

  • Medicare/Medicaid 38
  • Taxation/Internal Revenue Code 33
  • Health Issues 30
  • Medical/Disease Research/Clinical Labs 12
  • Pharmacy 10

Planned insider sales (Form 144) 9

Notices insiders file before they sell certain shares, such as ones they got straight from the company.

1 in the last 90 days · 9 notices on file

The notices on file don't give the sale's size; each sale shows up under company insiders once it is reported.

5% owners (13D / 13G) 3

Investors who reported owning 5% or more — 13D for owners who may push for changes, 13G for owners who just hold.

Push for changes, or just hold?

  • 13D, may push for changes: 1 filing
  • 13G, just holds: 2 filings

Filed by State Street Corp · Vanguard Portfolio Management LLC · Baker Bros. Advisors LP

Biggest named funds (13F)

The largest ACAD holdings among the well-known funds whose quarterly 13F filings we read — opens here.

Every disclosed trade on ACAD

  1. ▼ SELLMark C. Schneyer EVP, Chief Financial OfficerACAD Acadia Pharmaceuticals Inc$273Kdisclosed Aug 7 · filed 1 day after the trade
  2. ▼ SELLMark C. Schneyer EVP, Chief Financial OfficerACAD Acadia Pharmaceuticals Inc$170Kdisclosed Aug 7 · filed 2 days after the trade
  3. ▼ SELLMark C. Schneyer EVP, Chief Financial OfficerACAD Acadia Pharmaceuticals Inc$145Kdisclosed Aug 7 · filed 1 day after the trade
  4. ▼ SELLElizabeth H.Z. Thompson EVP, Head of Research & DevACAD Acadia Pharmaceuticals Inc$431Kdisclosed Jul 31 · filed 1 day after the trade
  5. ▼ SELLElizabeth H.Z. Thompson EVP, Head of Research & DevACAD Acadia Pharmaceuticals Inc$1.3Kdisclosed Jul 31 · filed 1 day after the trade
  6. ▼ SELLJames Kihara Principal Accounting OfficerACAD Acadia Pharmaceuticals Inc$298Kdisclosed Jun 29 · filed 3 days after the trade
See the trades on ACAD in the feed →
People & votes

Which members of Congress traded ACAD, sponsored bills that touch it and voted on them — opens here.